circular DNA technology
Transforming sequencing and diagnostics with Geno1®
With next-generation sequencing, we became readers of DNA. With synthetic chemistry, we became writers of DNA. With circular DNA, we’re becoming scholars.
Unified foundation for sequencing and diagnostics
In our vision, DNA sequences are no longer static records but dynamic units, capable of supporting database operations as seamlessly as today’s digital systems. This unified approach will transform sequencing applications, making DNA data more accessible, interactive, and integral to modern solutions.
GENO1® TECHNOLOGY
BRIDGE CAPTURE™
GENO1® TECHNOLOGY
NICKING LOOP™
Leveraging circular DNA for simplicity, specificity and high fidelity
With Geno1® technologies, we are committed to unsurpassed data quality on established as well as emerging sequencing platforms. Deploy Geno1® technologies anywhere, on any sequencing platform, free of infrastructure constraints.
-
Simple and rapid
Genomill’s tests are engineered for simplicity and speed, utilizing standard laboratory infrastructure combined with minimal sample processing.
-
Cost-efficient
Genomill’s test use off-the-shelf reagents and standard laboratory infrastructure. This combined with low sequencing requirement leads to unparalleled cost-efficiency.
-
Platform-agnostic
Genomill’s tests are compatible with all currently available sequencing platforms. The Geno1® libraries can be sequenced directly in their circular form or converted into linear libraries to fit seamlessly with any workflow.
-
Sensitive detection
Geno1® delivers proven sensitivity, meeting the rigorous demands of even the most challenging oncological applications.
News
Bridge Capture™ by Genomill represents a major leap forward in liquid biopsy diagnostics
Genomill and Finland’s Cancer Research Flagship iCAN Partner To Improve Cancer Detection Using an Extensive Biobank Cohort
Genomill appoints former Foundation Medicine executive and plans to present unmatched data at PMWC